(Q35599939)

9 August 2017

1 reference

title

Prostate cancer management: 2. An update on locally advanced and metastatic disease (English)

1 reference

9 August 2017

1 reference

Bott SR

1

1 reference

9 August 2017

Birtle AJ

series ordinal

2

1 reference

9 August 2017

Taylor CJ

series ordinal

3

1 reference

9 August 2017

Kirby RS

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Postgraduate Medical Journal

9 August 2017

1 reference

9 August 2017

79

1 reference

9 August 2017

937

1 reference

9 August 2017

643-645

1 reference

Prostate cancer management: (1) an update on localised disease

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Treatment of clinical local failure after radiation therapy for prostate carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742876

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

26 September 2018

1 reference

12 December 2020

A pilot study of intermittent androgen deprivation in advanced prostate cancer

1 reference

12 December 2020

Intermittent androgen suppression in the management of prostate cancer

1 reference

12 December 2020

Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer

1 reference

12 December 2020

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinom

1 reference

12 December 2020

Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma

1 reference

12 December 2020

Thromboprophylaxis in the cancer patient

1 reference

12 December 2020

Identifiers

DOI

10.1136/PMJ.79.937.643

1 reference

9 August 2017

1 reference

9 August 2017

1 reference